Apellis Pharmaceuticals Inc

+1.46 (+1.70%)
5:18:01 PM EDT: $87.31 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.17B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$63.24 Million
Adjusted EPS-$1.37
See more estimates
10-Day MA$86.91
50-Day MA$81.57
200-Day MA$62.86
See more pivots

Apellis Pharmaceuticals Inc Stock, NASDAQ:APLS

100 5th Avenue, Suite A, Waltham, Massachusetts 02451-8703
United States of America
Phone: +1.617.977.5700
Number of Employees: 767


Apellis Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.